WHO ICTRP trial
Clinical study to compare efficacy and safety of Intas Ranibizumab with…
EUCTR2021-001970-41-LV · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2021-001970-41-LV |
|---|---|
| Public title | Clinical study to compare efficacy and safety of Intas Ranibizumab with Lucentis. |
| Scientific title | A Double Masked, Parallel Group, Randomized, Multicenter, Clinical Study to Compare Efficacy and Safety of Intas Ranibizumab with Lucentis® in Patients with Neovascular (Wet) Age-Related Macular Degeneration (AMD). - CLARITY |
| Primary sponsor | Intas Pharmaceuticals Ltd. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Czechia;Hungary;Estonia;Poland;Ukraine;Russian Federation;Latvia;India |
| Conditions | Neovascular (Wet) Age-Related Macular Degeneration (AMD) MedDRA version: 20.0 Level: PT Classification code 10071129 Term: Neovascular age-related macular degeneration System Organ Class: 10015919 - Eye disorders ;Therapeutic area: Diseases… |
| Interventions | Trade Name: Lucentis Pharmaceutical Form: Solution for injection in vial INN or Proposed INN: RANIBIZUMAB CAS Number: 347396-82-1 Concentration unit: mg/ml milligram(s)/millilitre Concentration type: equal Concentration number: 10- Trade… |
| Registration date | Feb 17, 2022 |
| Target size | 546 |
| Secondary IDs | 0504-19;2021-001970-41-HU |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: